Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Minority Interest (2017 - 2021)

Innoviva (INVA) has disclosed Minority Interest for 6 consecutive years, with $177.1 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Minority Interest rose 176.91% year-over-year to $177.1 million, compared with a TTM value of $177.1 million through Jun 2022, up 176.91%, and an annual FY2021 reading of $111.2 million, up 63.7% over the prior year.
  • Minority Interest was $177.1 million for Q2 2022 at Innoviva, up from $111.2 million in the prior quarter.
  • Across five years, Minority Interest topped out at $177.1 million in Q2 2022 and bottomed at $811000.0 in Q1 2018.
  • Average Minority Interest over 5 years is $45.4 million, with a median of $28.6 million recorded in 2019.
  • The sharpest move saw Minority Interest surged 3498.03% in 2018, then soared 63.7% in 2021.
  • Year by year, Minority Interest stood at $5.5 million in 2018, then soared by 423.33% to $28.6 million in 2019, then soared by 137.33% to $67.9 million in 2020, then skyrocketed by 63.7% to $111.2 million in 2021, then skyrocketed by 59.3% to $177.1 million in 2022.
  • Business Quant data shows Minority Interest for INVA at $177.1 million in Q2 2022, $111.2 million in Q4 2021, and $89.0 million in Q3 2021.